Lyophilization Services for Biopharmaceuticals Market Forecast to 2027 - COVID-19 Impact and Global Analysis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Lyophilization Services for Biopharmaceuticals Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Service Type, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the global lyophilization service for biopharmaceutical market is expected to reach US$ 1,456.74 million by 2027 from US$ 702.06 million in 2019; it is estimated to grow at a CAGR of 9.7% from 2020 to 2027.

The report highlights the trends prevalent in the global lyophilization service for biopharmaceuticals market, and the drivers and deterrents pertaining to its growth.

Based on service type, the lyophilization service for biopharmaceuticals market is segmented into product and cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. In terms of service type, the commercial manufacturing segment held the highest share of the lyophilization services for biopharmaceuticals market in 2019; however, the product and cycle development segment is anticipated to witness a significant growth rate during the forecast period.

The growth of the market is attributed to the advantages offered by the lyophilization process such as increased shelf life for both small and large molecule drugs, stabilizing formulation by commercially validated method, and reduces cost for complex logistics such as rigorous cold-chain custody validation regimes and constant documentable refrigeration at the dispensary level.

The growth of the market is attributed to the factors such as rising demand for lyophilized products, and rapid growth in contract manufacturing and lyophilization services across the world. On the other hand, the demerits associated with lyophilization process such as leakage during filling, are the major factors hindering the market growth.

Market Dynamics

Drivers

• Rising Demand for Lyophilized Products
• Rapid Growth in Contract Manufacturing and Lyophilization Services Across the World

Restraints

• Demerits Associated with Lyophilization Process

Opportunities

• Strategic Activities by Key Players

Future Trends

• Growth in the Number of siRNA and Antibody Based Formulations

Companies Profiled

• ATTWILL Medical Solutions
• Axcellerate Pharma LLC
• AB BioTechnologies, Inc. (AB)
• Berkshire Sterile Manufacturing
• LSNE Contract Manufacturing
• AMRI
• Emergent BioSolutions Inc.
• Jubilant HollisterStier LLC.
• Biofortuna
• Lyophilization Technology, Inc.
• SYNERLAB GROUP

For more information about this report visit https://www.researchandmarkets.com/r/6s9qaz